Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Methodologic Issues

J Thorac Oncol. 2024 Apr;19(4):e1-e2. doi: 10.1016/j.jtho.2024.01.008.

Authors

Chi-Chuan Chiou¹, Tzu-Yu Lai²

Affiliations

¹ Department of Heavy Particles & Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
² Department of Heavy Particles & Radiation Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chao Tung University, Taipei, Taiwan; Institute of Public Health, National Yang Ming Chao Tung University, Taipei, Taiwan. Electronic address: tylai@vghtpe.gov.tw.

PMID: 38582548
DOI: 10.1016/j.jtho.2024.01.008

No abstract available

Publication types

Letter

MeSH terms

Chemoradiotherapy
Esophageal Neoplasms* / radiotherapy
Esophageal Squamous Cell Carcinoma* / radiotherapy
Humans
Lung Neoplasms*
Proton Therapy*
Radiotherapy Dosage
Radiotherapy, Intensity-Modulated*